Table of contents

Original articles

Heart failure and cardiomyopathy

• Low circulating androgens and mortality risk in heart failure (28 October, 2009)

  G Güder, S Frantz, J Bauersachs, B Allolio, G Ertl, C E Angermann, S Störk
• Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience (1 November, 2009)

  Atul Verma, Zaev Wulffhart, Dhanunjaya Lakkireddy, Yaariv Khaykin, Alexander Kaplan, Bradley Sarak, Mazda Biria, Jayasree Pillarisetti, Pradeep Bhat, Luigi Di Biase, Otto Constantini, Kara Quan, Andrea Natale
• Dynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathy (29 March, 2010)

  Giovanni Quarta, Deirdre Ward, María T Tomé Esteban, Antonios Pantazis, Perry M Elliott, Massimo Volpe, Camillo Autore, William J McKenna

Myocarditis

• Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity (29 March, 2010) Free

  Keiichi Hishikari, Ryo Watanabe, Masahito Ogawa, Jun-ichi Suzuki, Mayumi Masumura, Tomoko Shimizu, Kiyoshi Takayama, Yasunobu Hirata, Ryozo Nagai, Mitsuaki Isobe

LV dysfunction

• Progression of preclinical diastolic dysfunction to the development of symptoms (29 March, 2010)

  Daniel D Correa de Sa, David O Hodge, Joshua P Slusser, Magaret M Redfield, Robert D Simari, John C Burnett, Horng H Chen
• Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction (29 March, 2010)

  James H Park, Sean Balmain, Colin Berry, John J Morton, John J V McMurray

Valvular heart disease

• Gender differences in clinical presentation and surgical outcome of aortic stenosis (29 March, 2010)

  Christina Fuchs, Julia Mascherbauer, Raphael Rosenhek, Elisabeth Pernicka, Ursula Klaar, Christine Scholten, Maria Heger, Gregor Wollenek, Martin Czerny, Gerald Maurer, Helmut Baumgartner

Heart rhythm disorders

• Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during ‘pill-in-the-pocket’ treatment (29 March, 2010)

  Paolo Alboni, Giovanni L Botto, Giuseppe Boriani, Giovanni Russo, Federico Pacchioni, Matteo Iori, Giovanni Pasanisi, Marina Mancini, Barbara Mariconti, Alessandro Capucci